This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Menu
Book
keyboard_arrow_right

CONFERENCE DAY THREE - EST/EDT (Eastern Daylight, GMT-4)

search

CONFERENCE DAY THREE - EST/EDT (Eastern Daylight, GMT-4)

search
7:55am - 8:00am5 mins
Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
Chairperson’s Opening Remarks
    8:00am - 8:30am30 mins
    Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
    State of the Industry
    • Janet Lambert - Chief Executive Officer, Alliance for Regenerative Medicine
    8:30am - 9:30am60 mins
    Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
    Panel Discussion: Exploring the Massachusetts Biotech Ecosystem; Fostering Innovation, Spinning out, & Maximising Growth Potential
    • Shashi Murthy, PhD - Founder & CTO, Flaskworks
    • Brian Goodman, PhD - Partner, MPM
    • Jennifer Griffin - VP Industrial Strategy & Investments, Mass Life Sciences
    8:30am - 9:00am30 mins
    Bio fabrication – The Path to Commercialization: In collaboration with ARMI
    Opening remarks and Manufacturing the Future of Biofabrication with ARMI
      9:00am - 9:30am30 mins
      Bio fabrication – The Path to Commercialization: In collaboration with ARMI
      Tools and Technologies for Generating High Quality Cellular Starting Material
        9:30am - 10:15am45 mins
        Networking Refreshment Break
          10:15am - 11:00am45 mins
          Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
          Panel: Investment view on Innovation in Cell & Gene Therapy
          • Shaan Gandhi - Director, Northpond Ventures
          • Walter Kowtonuik - Principal, Third Rock
          • Shin Fuse - Managing Director, MPM Capital
          • Michal Preminger, Ph.D., MBA - Head, J&J Innovation, East North America, J&J
          10:15am - 10:45am30 mins
          Bio fabrication – The Path to Commercialization: In collaboration with ARMI
          Streamlining Production of Defined Cell Lines
            10:45am - 11:15am30 mins
            Bio fabrication – The Path to Commercialization: In collaboration with ARMI
            Label-free Cell Selection and Purification
              11:00am - 12:00pm60 mins
              Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
              Dual Dialogue – Anatomy of an Acquisition: Bayer and AskBio
              • Sheila Mikhail - CEO & Co-Founder, AskBio
              • Marianne De Backer, MBA, PhD - EVP, Head of Strategy, BD&L, Bayer
              11:15am - 11:45am30 mins
              Bio fabrication – The Path to Commercialization: In collaboration with ARMI
              Sensors for Real-time and Non-destructive Detection of Product Quality Attributes
                11:45am - 12:00pm15 mins
                Bio fabrication – The Path to Commercialization: In collaboration with ARMI
                Spotlight Presentation
                  12:00pm - 1:00pm60 mins
                  Networking Luncheon
                    1:00pm - 1:45pm45 mins
                    Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
                    Panel: Manufacturing and Distribution Strategies for Commercialising Cell & Gene Therapies
                    • Anne Altmeyer - Formerly, CBO, Sigilon Tx
                    • Kareem Reda - CBO, Elevate Bio
                    1:00pm - 1:30pm30 mins
                    Bio fabrication – The Path to Commercialization: In collaboration with ARMI
                    Scaling the Production of Tissues Using 3D Printing
                      1:30pm - 2:00pm30 mins
                      Bio fabrication – The Path to Commercialization: In collaboration with ARMI
                      Generating Complex Scaffolds and Harnessing Native Material Architecture
                        1:45pm - 2:30pm45 mins
                        Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
                        Panel: Talent Acquisition, Development and Retention in Novel Therapeutics
                        • Andrew Rigoglioso - Associate Director, Talent Acquisition, Cell Therapy Development & Operations, BMS
                        • Juliette Hilliard - Director, Talent Acquisition, Novartis GT
                        • Georgette Verdin - Chief HRO, Avrobio
                        2:00pm - 2:30pm30 mins
                        Bio fabrication – The Path to Commercialization: In collaboration with ARMI
                        Maturation Techniques and Bioreactor Culture for Tissue Generation
                          2:30pm - 3:00pm30 mins
                          Networking Refreshment Break
                            3:00pm - 3:45pm45 mins
                            Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
                            Panel: A Global View of Value, Regulatory Considerations & Access for Novel Therapies
                            • Greg White - Senior Director , Global Market Access Policy, Janssen
                            • Kristin Wolff - Senior Director, Global Government Affairs & Public Policy, Bluebird
                            • Manal Morsy - Senior Vice President, Head Global Regulatory Affairs, Athersys, Inc.
                            • Roland DeAngelis - SVP, Commercial Operations, Vericel (pernding final confirmation)
                            3:00pm - 3:30pm30 mins
                            Bio fabrication – The Path to Commercialization: In collaboration with ARMI
                            Maturation Techniques and Bioreactor Culture for Tissue Generation
                              3:30pm - 4:00pm30 mins
                              Bio fabrication – The Path to Commercialization: In collaboration with ARMI
                              Trends for the Future of Biomanufacturing
                                3:45pm - 4:30pm45 mins
                                Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
                                Panel: Patient Case Management & Developing Patient journey methods for Cell & Gene Therapies
                                • Shefali Shah - Independent Consultant, Indi
                                • Sarah Nikiforow - Asst. Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility, Dana-Farber Cancer Institute
                                • Kris Elverum - SVP, BD & Strategy, Rubius Tx
                                4:00pm - 4:30pm30 mins
                                Bio fabrication – The Path to Commercialization: In collaboration with ARMI
                                End of Day
                                  CONFERENCE DAY TWO
                                  Choose Day